| Department of Defense awards $1.6B contract for COVID-19 monoclonal antibody ... | Department of Defense | $1.6B | N/A |
| HHS awarded GlaxoSmithKline $682M for vaccines, with a significant portion fo... | Department of Health and Human Services | $682.2M | N/A |
| HHS awarded $602M for childhood vaccines, with GSK as the sole contractor und... | Department of Health and Human Services | $602.0M | N/A |
| HHS awards $555M contract for childhood vaccines to GlaxoSmithKline, LLC. | Department of Health and Human Services | $554.8M | N/A |
| HHS awarded $526M for childhood vaccines, with CDC managing this firm-fixed-p... | Department of Health and Human Services | $526.1M | N/A |
| DoD awards $335.6M to GlaxoSmithKline for vaccine adjuvant, raising questions... | Department of Defense | $335.6M | N/A |
| DoD awards $280M for COVID-19 therapeutic Sotrovimab, a sole-source pharmaceu... | Department of Defense | $279.9M | N/A |
| HHS Awards $90.9M Contract for Adult Flu Vaccine to GlaxoSmithKline | Department of Health and Human Services | $90.9M | N/A |
| HHS CDC Awards $66.4M Firm Fixed Price Task Order to GlaxoSmithKline for Biol... | Department of Health and Human Services | $66.4M | N/A |
| HHS awards $56M for pharmaceutical prep manufacturing to GlaxoSmithKline, LLC. | Department of Health and Human Services | $56.0M | N/A |
| HHS awarded $51M for pediatric flu vaccine, with GSK as the sole supplier. | Department of Health and Human Services | $51.0M | N/A |
| HHS awarded $50.7M for pediatric flu vaccines, with GlaxoSmithKline securing ... | Department of Health and Human Services | $50.7M | N/A |
| HHS awards $50M for biological product manufacturing, with a focus on shelf-l... | Department of Health and Human Services | $50.0M | N/A |
| HHS Spent $49.6M on Pediatric Flu Vaccines from GlaxoSmithKline in 2014-2015 | Department of Health and Human Services | $49.6M | N/A |
| HHS awards $40.6M for Biological Product Manufacturing in FY18 to GlaxoSmithK... | Department of Health and Human Services | $40.6M | N/A |
| HHS Awards $33M Task Order to GlaxoSmithKline for Biological Product Manufact... | Department of Health and Human Services | $33.0M | N/A |
| HHS awards $22.8M for influenza vaccine R&D, with GSK to develop H5N8 candidate. | Department of Health and Human Services | $22.9M | N/A |
| HHS awards $20.6M for Adult Vaccines to GlaxoSmithKline, LLC under full and o... | Department of Health and Human Services | $20.6M | N/A |
| HHS Awards $18.2M Task Order to GlaxoSmithKline for Pandemic Readiness and Me... | Department of Health and Human Services | $18.2M | N/A |
| HHS Awards $18.16M for Vaccine Clinical Study to GlaxoSmithKline, LLC | Department of Health and Human Services | $18.2M | N/A |
| HHS awards $7.79M for antigen storage, supporting biodefense R&D with a firm-... | Department of Health and Human Services | $7.8M | N/A |